Business Wire

OpenGate Capital Sells Getronics LATAM to Southern Cross Group

Del

OpenGate Capital, a global private equity firm, announced today it has completed the sale of Getronics LATAM to Southern Cross Group, a leading Latin American private investment firm. The exit yields greater than 11 times invested capital for OpenGate Capital. Financial terms of the transaction were not disclosed.

Getronics LATAM, with operations in Mexico, Colombia, Peru and Venezuela, is an integrated ICT products and services provider for the large enterprise market including workspace management services, connectivity, data centers and consultancy services.

OpenGate Capital first entered the Latin American market in 2010 through its acquisition of Sopho, a Brazilian IT services company, from Philips. As a strategic add-on, OpenGate Capital then acquired Getronics LATAM from KPN in 2012 to bring greater scale and operating strength across Brazil, Mexico and Colombia. The third phase of OpenGate Capital’s buy and build strategy was the acquisition of Damovo Latin American in 2014 from Damovo Europe. This acquisition added scale, operational capabilities and blue chip customers in Mexico and Brazil. All three acquisitions were made through OpenGate Capital’s legacy, pre-fund investment platform.

Throughout the investment period, OpenGate Capital and Getronics LATAM implemented several strategies to improve the overall value of the business including the following:

  • Cost savings initiatives
  • Consolidated operations
  • Accelerated growth in existing geographies and expanded into new geographies
  • Improved cross-selling product and services opportunities across a pan Latin American group
  • Divested the Brazil operations in January of 2016 to CimCorp

During OpenGate Capital’s ownership period and as a result of these strategies, there has been an increase in revenues of over 11 times and an increase in EBITDA of over five times and OpenGate Capital returned over 11 times its invested capital.

Andrew Nikou, OpenGate Capital’s founder, Managing Partner and CEO stated, “I am incredibly proud of our investment in Getronics LATAM and the value we created through our operational turnaround and accretive add-on efforts. Under our stewardship, we increased the value of the platform, doubling the EBITDA performance of Getronics. While the Latin American market was challenging, it did not deter us from pursuing what we believed would be a great investment. Through our strategy of working with local management teams and building a deeper understanding of each market’s particular dynamics, we successfully achieved our objectives. As Getronics LATAM transfers to Southern Cross Group we are confident that together they will continue on a path of growth.”

Leading the transaction on behalf of OpenGate Capital was Matthias Gundlach, Senior Principal in the firm’s Los Angeles office, who said, “As far back as 2010, OpenGate Capital saw tremendous potential in a business and a market that many other buyers shied away from given the complexities of integrating and operating a business in several counties. OpenGate built a team on the ground in Brazil and applied its turnaround and add-on acquisition strategies to drive value into the Getronics LATAM business. The sale of the business reflects the results of our efforts and today, Getronics LATAM is well positioned for growth under the ownership of Southern Cross Group given their deep domain knowledge in both the IT services industry and the Latin American market. We thank the team at Southern Cross and Getronics for their support throughout the transaction period.”

OpenGate’s Advisors on the transaction included KPMG Corporate Finance LLC as financial advisor, Morgan, Lewis & Bockius LLP as lead legal counsel, and KPMG LLP as lead tax advisor.

The sale of Getronics LATAM represents the sixth transaction in 2016 for OpenGate Capital following the firm’s acquisitions of Power Partners Inc, Bois et Matériaux, Energi Fenestration Solutions, Alfatherm and EverZinc, each of which was made through its first, private equity institutional fund.

About OpenGate Capital

OpenGate Capital is a global private equity firm specializing in the acquisition and operation of businesses seeking revitalization through growth and operational improvements. Established in 2005, OpenGate Capital is headquartered in Los Angeles, California and has a European office in Paris, France. OpenGate’s professionals possess the critical skills needed to acquire, transition, operate and build successful businesses. To date, OpenGate Capital, through its legacy and fund investments, has executed more than 30 acquisitions ranging from corporate divestitures to turnaround acquisitions, industry consolidations and other special-situation investments. To learn more about OpenGate, please visit www.opengatecapital.com.

About Southern Cross Group

Southern Cross Group is a leading Latin America private investment firm. Southern Cross Group's philosophy is to invest in Latin American companies who own assets that, when deployed with a focused strategy, led by an outstanding management team and unburdened with inappropriate capital structures, will seek to achieve a sustainable competitive advantage in their markets.

Contact information

OpenGate Media Contact
Alanna Chaffin, +1 310-432-7000
achaffin@opengatecapital.com
or
OpenGate Business Development Contact
Joshua Adams, +1 310-432-7000
jadams@opengatecapital.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

ViiV Healthcare Shares Data from Landmark 2-Drug Regimen Trials At AIDS 201818.7.2018 17:21Pressemelding

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, will be presenting over 20 abstracts, including data from the landmark GEMINI 1 & 2 clinical trials, at the 22nd International AIDS Conference (AIDS 2018), 23-27 July 2018, in Amsterdam, The Netherlands. The data being presented this year has a strong focus on novel exploratory therapeutic options and innovative treatment strategies, as well as improving awareness and understanding of key issues that continue to affect the HIV community. John C Pottage, Jr, MD, Chief Scientific and Medical Officer, ViiV Healthcare, commented, “As we see advancements in the treatment options available to people living with HIV, our research efforts over the past few years have been focused on moving beyond viral load and addressing some of the unresolved issues that people living with HIV face, such as the potential long-term risks and toxicities that can be associated with li

Xilam: H1 2018 Revenue: +50%18.7.2018 16:00Pressemelding

Regulatory News: The Xilam Group (Paris:XIL) posted consolidated H1 2018 revenue of EUR 13,866 thousand, an increase of 50%. This increase represents an excellent performance, as it follows on the heels of growth of 54% in H1 2017. Revenue for the first part of this financial year breaks down as follows. In thousands of euros 30.06.2018 (1) 30.06.2017 Change New productions 8,465 4,571 +85% Catalogue 5,385 4,652 +16% Other 16 16 +0% Revenue and subsidies 13,866 9,239 +50% (1) Unaudited data. Remarkable success for new releases +85% Excellent H1 growth was driven by the two main businesses, New Productions and Catalogue. In New Productions, H1 deliveries generated record revenue of EUR 8,465 thousand, an 85% increase compared with H1 2017, and confirmed Xilam’s position as a major European animation company. Catalogue revenue was up 16% compared with H1 2017, thanks again to traditional TV channels and digital platforms, in both France and abroad. A fast-paced delivery schedule Thanks t

Department for International Trade: Life Sciences at the Heart of UK Economy18.7.2018 12:38Pressemelding

The Government will today (Wednesday 18 July) host the second in a series of roundtables with stakeholders from key life science businesses, demonstrating the importance of the sector to the UK economy. The Chancellor, International Trade Secretary, Business Secretary and Health and Social Care Secretary will be amongst those that meet with senior representatives from leading UK and international life sciences companies as the UK positions itself as the global home of health innovation, welcoming overseas investment and seeking to boost exports in the process. Discussions at the roundtable will focus on how the future of the Life Sciences sector will be supported by the delivery of our modern Industrial Strategy, ensuring that the UK is ‘open for business’ with a positive business environment, our ambitions for a comprehensive agreement with the EU on our future relationship and the development and implementation of our independent trade policy. To date, the government has engaged sign

Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials18.7.2018 12:05Pressemelding

Universal Laser Systems (ULS) announces the addition of 3M™, Victrex® and Dexmet materials to its materials database, the most extensive repository of laser material processing parameters for materials in the range of 10 watts to 500 watts. The 3M, Victrex and Dexmet materials new to the ULS materials database were specifically added for laser processing with the ULTRA and XLS platforms, suited for high accuracy and precision laser cutting, laser ablation and laser surface modification. The materials include: 3M™ Extreme Sealing Tape 4412N 3M™ Thermally Conductive Silicone Interface Pad 5516 Victrex® APTIV® PEEK Film Dexmet PolyGrid® 8PTFE10-125ST Expanded PTFE Dexmet MicroGrid® AL 25 Expanded Aluminum Laser processing notes, describing the results of the laser-material interaction for these materials, are also available in the Materials Library on the ULS website to help potential customers explore the advantages of deploying laser technology within their manufacturing, research and d

Sterigenics Expands European Capacity With New State-of-the-Art Gamma Sterilization Facility in the UK18.7.2018 12:00Pressemelding

Sterigenics, a Sotera Health company and leading global provider of mission-critical sterilization solutions and expert advisory services, announced today it is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK. The facility will significantly expand Sterigenics’ footprint in Europe to help meet the growing sterilization needs of its customers and support the company’s mission of Safeguarding Global HealthTM. Scheduled for completion in the fourth quarter, 2018, the facility will include the installation of a state-of-the-art Nordion JS10000 gamma irradiator with a research loop. The new 60,000-square-foot facility will add gamma sterilization capabilities in the UK to complement Sterigenics’ existing ethylene oxide (EtO) facility based in Somercotes/Derbyshire. “Sterigenics is committed to being the world’s leading provider of sterilization services and partnering with our customers to eliminate threats to human health,” said Philip Macnabb, President of Ste

Smiths Detection Technology Chosen for Standard 3 Upgrade at Helsinki Airport18.7.2018 09:05Pressemelding

Smiths Detection has been selected by Finnish airport operator, Finavia Corporation, to support the transition to Standard 3 at Helsinki Airport with approved hold baggage screening systems. Included in the contract are eight high-speed, HI-SCAN 10080 XCT scanners, which combine high resolution X-ray technology, computed tomography (CT) and advanced detection algorithms to increase both security and operational efficiency significantly. Security, speed and efficiency are critical to the extensive development programme underway at the airport, which will allow the airport to serve 30 million passengers annually and increase baggage handling capacity by 50%. “Any financial investment in upgrading security equipment has to be balanced against operational improvement, particularly when part of a major expansion. Airports need assurance that efficiencies will be gained and systems can be further updated as necessary to detect evolving explosive threats and handle ever higher volumes,” comme